Skip to content

Amesite Inc.: 10-Q filed 2023-05-15

What Amesite Inc. reported in its quarterly report filed 2023-05-15 (fiscal Q3 2023): 27 published measures, 85 facts as tagged in accession 0001213900-23-039842.

This filing

Form
10-Q (quarterly report)
Filed
2023-05-15
Fiscal period
fiscal Q3 2023
Accession
0001213900-23-039842 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Amesite Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2023-03-017,268,354USD
At 2022-06-308,883,860USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2023-03-316,957,183USD
At 2023-03-016,957,183USD
At 2022-12-317,879,250USD
At 2022-09-308,645,944USD
At 2022-06-308,135,752USD
At 2021-12-319,229,003USD
At 2021-09-3011,106,018USD
At 2021-06-3011,735,090USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2023-01-01 to 2023-03-31-927,997USD90
2022-07-01 to 2023-03-31-3,204,819USD274
2022-10-01 to 2022-12-31-699,484USD92
2022-07-01 to 2022-09-30-1,577,338USD92
2022-01-01 to 2022-06-30-2,216,111USD181
2022-01-01 to 2022-03-31-2,216,112USD90
2021-07-01 to 2022-03-31-6,916,507USD274
2021-10-01 to 2021-12-31-2,322,239USD92
2021-07-01 to 2021-09-30-2,378,157USD92

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2022-07-01 to 2023-03-31-2,583,495USD274
2021-07-01 to 2022-03-31-5,088,820USD274

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2022-07-01 to 2023-03-315,554USD274
2021-07-01 to 2022-03-3114,267USD274

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2023-01-01 to 2023-03-31204,589USD90
2022-07-01 to 2023-03-31722,010USD274
2022-01-01 to 2022-03-31209,518USD90
2021-07-01 to 2022-03-31539,383USD274

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2022-07-01 to 2023-03-311,850,501USD274
2021-07-01 to 2022-03-313,869,550USD274

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2022-07-01 to 2023-03-31-293,763USD274
2021-07-01 to 2022-03-31-588,390USD274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2023-03-01-32,481,835USD
At 2022-06-30-29,277,016USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2023-01-01 to 2023-03-312,528,845shares90
2022-07-01 to 2023-03-312,445,845shares274
2022-01-01 to 2022-03-311,983,572shares90
2021-07-01 to 2022-03-311,818,724shares274

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2023-01-01 to 2023-03-31-0.37USD/shares90
2022-07-01 to 2023-03-31-1.31USD/shares274
2022-01-01 to 2022-03-31-1.12USD/shares90
2021-07-01 to 2022-03-31-3.8USD/shares274

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2023-01-01 to 2023-03-31-0.37USD/shares90
2022-07-01 to 2023-03-31-1.31USD/shares274
2022-01-01 to 2022-03-31-1.12USD/shares90
2021-07-01 to 2022-03-31-3.8USD/shares274

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2023-03-0173,733USD
At 2022-06-3087,190USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2022-07-01 to 2023-03-31103,809USD274
2021-07-01 to 2022-03-311,226,357USD274

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2023-01-01 to 2023-03-31-945,478USD90
2022-07-01 to 2023-03-31-3,239,728USD274
2022-01-01 to 2022-03-31-2,212,270USD90
2021-07-01 to 2022-03-31-6,918,539USD274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2023-03-016,346,356USD
At 2022-06-307,729,996USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2023-03-01311,171USD
At 2022-06-30748,108USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2023-03-0194,491USD
At 2022-06-30122,285USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2023-01-01 to 2023-03-311,150,067USD90
2022-07-01 to 2023-03-313,961,738USD274
2022-01-01 to 2022-03-312,421,788USD90
2021-07-01 to 2022-03-317,457,922USD274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2023-03-012,542,440shares
At 2022-06-302,166,124shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2023-03-316,128,610USD
At 2022-06-307,155,367USD
At 2022-03-318,905,431USD
At 2021-06-3010,713,091USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2023-03-0139,438,763USD
At 2022-06-3037,412,551USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2023-03-01173,996USD
At 2022-06-30560,084USD

Current contract liabilities

Consideration received before performance obligations are satisfied, often called deferred revenue. It is an obligation to deliver, not earned revenue or cash available.

PeriodValueUnitDays
At 2023-03-31105,980USD
At 2022-06-30342,672USD
At 2022-03-01219,190USD
At 2021-06-30333,200USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2023-01-01 to 2023-03-31653,128USD90
2022-07-01 to 2023-03-311,945,796USD274
2022-01-01 to 2022-03-311,239,153USD90
2021-07-01 to 2022-03-313,926,901USD274

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2022-07-01 to 2023-03-31525,631USD274
2021-07-01 to 2022-03-31682,068USD274

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2022-07-01 to 2023-03-31-29,205USD274
2021-07-01 to 2022-03-3140,325USD274

Inspect the source

Entity
Amesite Inc. / CIK 0001807166
Captured
2026-09-21T17:28:03.682Z
SEC response SHA-256
461c5975337814f2ee2af0d6667a281ad65728a8a27803451b3699350e7124cc

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001807166.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))